TNFSF10 and neoplasm: Our previous studies using recombinant TRAIL anchored to the surface of liposomes (LUV-TRAIL) demonstrated that this new formulation was much more potent than soluble TRAIL both in different tumor types both in vitro and in vivo [22,23,24].